March 2014 - Panelists Myron S. Czuczman, MD, (Roswell Park) Steve M. Horwitz, MD, (MSKCC), Lauren C. Pinter-Brown, MD, (UCLA), Andrei R. Shustov, MD, (SCCA) and Anas Younes, MD, (MSKCC) discuss the approval of brentuximab vedotin for patients with systemic anaplastic large-cell lymphoma and the continued investigation of the drug in other CD30-positive lymphoid malignancies on episode of OncLive.
Watch the video of their discussion here: http://www.onclive.com/peer-exchange/lymphoma/Brentuximab-Vedotin-in-CD3...
This is an automatic translation service and therefore the
Cutaneous Lymphoma Foundation is not responsible
for any potential translation inaccuracies.